This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ESOU18
ESOU18
Prostate Cancer
Renal Cancer
Bladder Cancer
Testis & Penile Cancers
ESOU18 Prostate Cancer
Viewing 1-20 of 23 articles
ESOU18: Open vs Robotic Surgery for Locally Advanced Prostate Cancer: Oncological and Functional Outcomes
ESOU18: Radiotherapy Treatment for Oligometastatic Prostate Cancer Disease
ESOU18: Is Lymph Node Dissection Necessary in Prostate Cancer? The European Perspective
ESOU18: Is Lymph Node Dissection Necessary in Prostate Cancer? The American Perspective
ESOU18: Reappraisal of Neoadjuvant Therapy for High and Very High-risk Prostate Cancer - Yes
ESOU18: Reappraisal of Neoadjuvant Therapy for High and Very High-risk Prostate Cancer - No
ESOU18: Salvage Radical Prostatectomy – Robotic
ESOU18: Tools for Detection of Node Metastasis: PSMA Guided Surgery
ESOU18: Salvage Radiotherapy for Prostate Cancer
ESOU18: Salvage Cryoablation for Prostate Cancer
ESOU18: Treatment Modalities for Intermediate Risk Prostate Cancer - Active Surveillance
ESOU18: Treatment Modalities for Intermediate Risk Prostate Cancer - Focal Therapy
ESOU18: Treatment Modalities for Intermediate Risk Prostate Cancer - Hypofractionation Radiotherapy
ESOU18: Treatment Modalities for Intermediate Risk Prostate Cancer - Surgery
ESOU18: How Have Recommendations Against Prostate Cancer Screening Impacted the Incidence and Mortality of Prostate Cancer in the US?
ESOU18: Biopsy or Monitoring Patients with Negative MRI
ESOU18: Cognitive Prostate Biopsy
ESOU18: MRI in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations
ESOU18: MRI in-bore Guided Biopsies
ESOU18: MRI imaging Targeted Biopsy – Fusion Biopsy
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free